Moreover, administration of another PDE-5 inhibitor, yonkenafil, resulted in improved cognitive function, increased neurogenesis in the dentate gyrus and reduced activation of microglia and astrocytes in a transgenic AD mouse model (Zhu et al., 2015), therefore showing also anti-inflammatory effects. Here, PDE5A is linked to Alzheimer disease.